||A/Prof Chng Wee Joo, Deputy Director and Senior Principal Investigator at CSI Singapore, in his joint study with Duke-NUS Graduate Medical School has found that Telomerase, an enzyme responsible for cancer cells’ ability to divide, also triggers chronic inflammation. They are currently screening for Telomerase-targeted drugs which could potentially lead to the better control of inflammation in cancer and eventually lower healthcare expenses.
A/Prof Chng Wee Joo, Senior Principal Investigator at CSI Singapore was a recipient at the 2011 University Awards, which honours and recognizes members of the NUS community who through their consistently high performance and resolute commitment set new benchmarks in the areas of education, research and service. He was honoured with the “Young Researcher Award” for his work on myelomas and lymphomas.
Source: http://www.csi.nus.edu.sg/ws/about-us/awards-and-achievements (Cancer Science Institute of Singapore)